Navigation Links
Low adherence to biopsy guidelines affects celiac disease diagnosis in the United States
Date:7/7/2011

NEW YORK, NY (July 6, 2011) - A new study has found that most patients undergoing biopsy of the small intestine do not have the recommended number of samples to diagnose celiac disease. The study, published in the July 2011 issue of Gastrointestinal Endoscopy, analyzed a national database of biopsy specimens maintained by Caris Life Sciences (Irving, TX). More than 100,000 patients had a biopsy of the small intestine, but only 35 percent of them had at least four samples taken, the number recommended by professional guidelines.

Celiac disease is common, affecting approximately 1 percent of the population in the United States. However, the vast majority of patients with celiac disease in the United States have not been diagnosed. Many of these patients seek health care for symptoms including diarrhea, weight loss, or fatigue due to anemia. The diagnosis of celiac disease is made by biopsy of the small intestine, but factors related to the performance of biopsy may contribute to the under-diagnosis of celiac disease in the United States.

"Celiac disease can affect the small intestine in a patchy distribution, and so just one or two biopsy samples could potentially miss the evidence of the disease," said lead author Benjamin Lebwohl, MD, MS, a gastroenterologist at the Celiac Disease Center at Columbia University Medical Center, in New York. Dr. Lebwohl and co-authors aimed to measure the practice of small intestinal biopsy in the United States. The Caris pathology database consists of specimens submitted by gastroenterologists from 43 states as well as Puerto Rico and the District of Columbia. The team also compared the diagnosis rate among patients who had at least four specimens submitted, in accordance with guidelines.

The investigators identified 132,352 individuals who underwent biopsy between 2006 and 2009, for a variety of medical indications, including diarrhea, abdominal pain, esophageal reflux, and anemia. Only
'/>"/>

Contact: Cynthai Beckman
cb2280@columbia.edu
646-812-1212
Columbia University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Link between fracture prevention and treatment adherence not fully understood by patients
2. Novel technique changes lymph node biopsy, reduces radiaiton exposure
3. Novel technique changes lymph node biopsy, reduces radiation exposure
4. Montana State grads work helps diagnose skin cancer without a biopsy
5. Multicolor quantum dots aid in cancer biopsy diagnosis
6. Microfluidics-imaging platform detects cancer growth signaling in minute biopsy samples
7. Guidelines urge physical activity during pregnancy
8. The International Society for Stem Cell Research releases new guidelines
9. Publication sets guidelines across cancer therapies: Ensuring the best in patient management
10. Coral Disease Handbook: Guidelines for Assessment, Monitoring and Management
11. First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Conn. , Apr. 27, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... commence shipping to pre-order customers the first week of ... through the month of May. ... a significant milestone for the company as Wocket® enters ...
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... artificial sweeteners completely from waste water. What,s more, ... be present in our drinking water. Thanks to ... and analyses seven commonly used artificial sweeteners, Marco ... the Water Technology Center in Karlsruhe, Germany, were ...
... Plants or meat: That,s about all that fossils ... skull characteristics of a new species of parrot-beaked dinosaur ... fed on nuts and/or seeds. These characteristics present the ... "The parallels in the skull to that in ...
... The flow of water into and out from the cell ... at the University of Gothenburg, Sweden, have now found the gate ... which will be published in the journal PLoS Biology , ... growth of tumours. All living organisms must be able to ...
Cached Biology News:The bitter side of sweeteners 2Sands of Gobi Desert yield new species of nut-cracking dinosaur 2Discovery of the cell's water gate may lead to new cancer drugs 2
(Date:5/21/2015)... 2015  Susan Hedstrom, Executive Director of the ... dedicated to supporting research to advance the understanding ... that FPWR has received the organization,s largest donation ... contributed $1 million in support of the organization,s ... "Our gift signifies our tremendous ...
(Date:5/21/2015)... May 21, 2015 W. R. ... manufacturing facility in Worms, Germany has received good ... subsidiary of the International Pharmaceutical Excipient Council (IPEC) ... that produce its SYLOID® FP brand of pharmaceutical ... certification, following the Curtis Bay, Maryland (USA) and ...
(Date:5/21/2015)... , May 21, 2015 /PRNewswire/ - RepliCel ... clinical stage regenerative medicine company focused on the ... upcoming poster presentation at the International Society for ... for chronic Achilles tendinosis currently in a Phase ... May 29 th from 5:30 PM to ...
(Date:5/20/2015)... This year has been one of the harshest ... Pearl’s Premium Ultra Low Maintenance Lawn Seed comes to ... coming out of record bad weather. Offering new ... concerns related to water, health, and climate change, Pearl's ... the standard, water-wasting, chemical-treated standard lawn. Many homeowners ...
Breaking Biology Technology:The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
... ARIUS Research Inc., (TSX:,ARI), a biotechnology company ... therapeutics, today announced that it has entered ... Trop-2 Signal Transduction,Antibody Program with Laureate Pharma, ... located in Princeton, New,Jersey. ARIUS, Trop-2 antibody ...
... Products in 2008 - - Conference call to ... BRANFORD, Conn., Jan. 31 CuraGen Corporation,(Nasdaq: CRGN ) ... fiscal year ended December 31, 2007., CuraGen reported a ... million, or $0.20 per share, which included restructuring charges,totaling $2.7 ...
... report patient benefits, SUNNYVALE, Calif., Jan. 31 ... announced that it has extended,worldwide distribution of its ... the Middle East, Africa, and Asia now,have access ... wide variety,of surgical procedures., Sealing and dividing ...
Cached Biology Technology:ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody 2ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody 3ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 2CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 5CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 6CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 7Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology 2
... Clone/PAD: 3B8A10. ... to the C-terminal region ... Specificity: Specific for the ... Reactivity: Human (positive control: ...
...
Request Info...
... the first all-inclusive collection of key procedures ... System. Methods developed by the leaders in ... protocols. This book will guide you from ... construction and analysis, to production of your ...
Biology Products: